<!DOCTYPE html>
<html lang="en">
<head>
<meta name="robots" content="noindex, nofollow">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<title>Sintese Tjsp Planos Vs Sus — Judicialização da Saúde</title>
<style>
  :root {
    --bg: #f8f9fa; --card: #fff; --fg: #1a1a1a; --muted: #666;
    --border: #dee2e6; --accent: #0d6efd; --accent2: #198754;
  }
  * { box-sizing: border-box; margin: 0; padding: 0; }
  body {
    font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, sans-serif;
    background: var(--bg); color: var(--fg); line-height: 1.5;
  }

  main { padding: 1.5rem 2rem 3rem; max-width: 900px; margin: 0 auto; }

  .md-body { font-size: .92rem; line-height: 1.7; color: #1f2328; }
  .md-body h1 { font-size: 1.5rem; font-weight: 600; margin: 1.8rem 0 .8rem; padding-bottom: .3rem; border-bottom: 1px solid var(--border); }
  .md-body h2 { font-size: 1.25rem; font-weight: 600; margin: 1.6rem 0 .6rem; padding-bottom: .25rem; border-bottom: 1px solid var(--border); }
  .md-body h3 { font-size: 1.05rem; font-weight: 600; margin: 1.3rem 0 .5rem; }
  .md-body h4 { font-size: .95rem; font-weight: 600; margin: 1.1rem 0 .4rem; }
  .md-body h1:first-child { margin-top: 0; }
  .md-body p { margin: 0 0 .8rem; }
  .md-body ul, .md-body ol { margin: 0 0 .8rem; padding-left: 1.8rem; }
  .md-body li { margin-bottom: .25rem; }
  .md-body a { color: var(--accent); text-decoration: none; }
  .md-body a:hover { text-decoration: underline; }
  .md-body strong { font-weight: 600; }
  .md-body blockquote {
    margin: 0 0 .8rem; padding: .4rem 1rem;
    border-left: 4px solid var(--accent); background: #f0f4f8;
    color: #555; font-size: .88rem;
  }
  .md-body blockquote p:last-child { margin-bottom: 0; }
  .md-body code {
    font-family: "SFMono-Regular", Consolas, monospace;
    font-size: .85em; background: #eef1f5; padding: .15rem .35rem; border-radius: 4px;
  }
  .md-body pre {
    margin: 0 0 .8rem; padding: .9rem 1rem;
    background: #f6f8fa; border: 1px solid var(--border);
    border-radius: 6px; overflow-x: auto; line-height: 1.45;
  }
  .md-body pre code { background: none; padding: 0; font-size: .82rem; }
  .md-body table {
    width: 100%; border-collapse: collapse; margin: 0 0 .8rem;
    font-size: .85rem; display: block; overflow-x: auto;
  }
  .md-body th, .md-body td { padding: .45rem .7rem; border: 1px solid var(--border); text-align: left; }
  .md-body th { background: #f0f4f8; font-weight: 600; }
  .md-body tr:nth-child(even) td { background: #fafbfc; }
  .md-body hr { border: none; border-top: 1px solid var(--border); margin: 1.5rem 0; }
  .md-body img { max-width: 100%; }

  .meta-bar {
    font-size: .78rem; color: var(--muted); padding: .5rem 0 .8rem;
    border-bottom: 1px solid var(--border); margin-bottom: 1rem;
  }
  .meta-bar a { color: var(--accent); text-decoration: none; }
  .meta-bar a:hover { text-decoration: underline; }

  footer {
    text-align: center; padding: 1.5rem; font-size: .8rem; color: var(--muted);
    border-top: 1px solid var(--border); margin-top: 2rem;
  }
</style>
</head>
<body>

<style>
  .site-nav {
    position: sticky; top: 0; z-index: 100;
    background: #212529; display: flex; align-items: center;
    padding: 0 2rem; height: 3rem;
  }
  .site-nav .nav-brand {
    color: #fff; text-decoration: none; font-weight: 600; font-size: 1rem;
    margin-right: auto;
  }
  .site-nav .nav-brand:hover { color: #e9ecef; }
  .site-nav .nav-link {
    color: #adb5bd; text-decoration: none; font-size: .85rem;
    padding: 0 .75rem; height: 3rem; display: flex; align-items: center;
    background: none; border: none; cursor: pointer; font-family: inherit;
  }
  .site-nav .nav-link:hover, .site-nav .nav-link.active { color: #fff; }
  .nav-dropdown { position: relative; }
  .dropdown-menu {
    display: none; position: absolute; top: 3rem; right: 0;
    background: #fff; border: 1px solid var(--border); border-radius: 6px;
    box-shadow: 0 4px 16px rgba(0,0,0,.12); min-width: 220px;
    padding: .4rem 0; z-index: 200; max-height: 80vh; overflow-y: auto;
  }
  .nav-dropdown.open .dropdown-menu { display: block; }
  .dropdown-menu a {
    display: block; padding: .3rem 1rem; color: #1a1a1a;
    text-decoration: none; font-size: .82rem;
  }
  .dropdown-menu a:hover { background: #f0f4f8; }
  .dropdown-group-label {
    padding: .4rem 1rem .15rem; font-size: .68rem; font-weight: 700;
    color: #888; text-transform: uppercase; letter-spacing: .04em;
  }
  .dropdown-divider { border-top: 1px solid #eee; margin: .3rem 0; }
  .page-header {
    padding: .8rem 2rem; border-bottom: 1px solid var(--border); background: #fff;
  }
  .page-header h1 { font-size: 1.3rem; font-weight: 600; }
  .page-header p { color: var(--muted); font-size: .85rem; margin-top: .15rem; }
</style>

<nav class="site-nav">
  <a href="../index.html" class="nav-brand">Judicialização da Saúde</a>
  <a href="../paper/index.html" class="nav-link">Paper</a>
  <div class="nav-dropdown">
    <button class="nav-link">Docs &#9662;</button>
    <div class="dropdown-menu">
    <div class="dropdown-group-label">Research reference</div>
    <a href="../docs/README.html">Project Overview</a>
    <a href="../docs/summary.html">Research Summary</a>
    <a href="../docs/institutions.html">Institutional Background</a>
    <a href="../docs/data.html">Data Sources</a>
    <a href="../docs/methods.html">Empirical Methods</a>
    <a href="../docs/literature.html">Literature</a>
    <a href="../docs/theory.html">Theoretical Framework</a>
    <a href="../docs/hypotheses.html">Hypotheses & Evidence</a>
    <div class="dropdown-divider"></div>
    <div class="dropdown-group-label">Working notes</div>
    <a href="../docs/thinking.html">Open Questions & Ideas</a>
    <a href="../docs/decisions.html">Key Decisions</a>
    <a href="../docs/qa.html">Research Q&A</a>
    <div class="dropdown-divider"></div>
    <div class="dropdown-group-label">Task tracking</div>
    <a href="../docs/todo.html">Active Tasks</a>
    <a href="../docs/done.html">Completed Tasks</a>
    <div class="dropdown-divider"></div>
    <div class="dropdown-group-label">Communication</div>
    <a href="../docs/meetings.html">Meeting Notes</a>
    <a href="../docs/feedback.html">External Feedback</a>
    <div class="dropdown-divider"></div>
    <div class="dropdown-group-label">Court analysis</div>
    <a href="../docs/01-stf-reasoning-templates.html">STF Reasoning Templates</a>
    <a href="../docs/02-stj-repetitivos-patterns.html">STJ Repetitivos Patterns</a>
    <a href="../docs/03-tjsp-plans-vs-sus.html">TJSP: Plans vs SUS</a>
    <a href="../docs/04-conitec-pcdt-vs-courts.html">CONITEC vs Courts</a>
    <a href="../docs/05-interfederative-responsibility.html">Interfederative Responsibility</a>
    </div>
  </div>
  <div class="nav-dropdown">
    <button class="nav-link">Data &#9662;</button>
    <div class="dropdown-menu">
    <a href="../sources/tjsp.html">TJSP</a>
    <a href="../sources/datajud.html">DataJud</a>
    <a href="../sources/stf-stj.html">STF & STJ</a>
    <a href="../sources/trf3.html">TRF3</a>
    <a href="../sources/spending.html">Municipal Spending</a>
    <a href="../sources/legislation.html">Health Legislation</a>
    </div>
  </div>
  <a href="../references/index.html" class="nav-link active">References</a>
  <a href="../news/index.html" class="nav-link">News</a>
</nav>
<script>
document.querySelectorAll('.nav-dropdown > .nav-link').forEach(function(btn) {
  btn.addEventListener('click', function(e) {
    e.stopPropagation();
    var dd = btn.parentElement;
    var wasOpen = dd.classList.contains('open');
    document.querySelectorAll('.nav-dropdown.open').forEach(function(d) { d.classList.remove('open'); });
    if (!wasOpen) dd.classList.add('open');
  });
});
document.addEventListener('click', function() {
  document.querySelectorAll('.nav-dropdown.open').forEach(function(d) { d.classList.remove('open'); });
});
</script>

<div class="page-header">
  <h1>Sintese Tjsp Planos Vs Sus</h1>
</div>

<main>
<div class="meta-bar">
  <a href="index.html">&larr; All reference docs</a> &middot; Sinteses Analiticas
</div>
<div class="md-body">
<hr />
<p>fonte: Análise do projeto
tipo: doutrina
relevancia: Síntese comparando argumentação em casos de planos vs SUS no TJSP.
uso_judicial: Diferenças de tratamento judicial entre saúde pública e privada.
data_processamento: 2026-02-09
arquivo_origem: 03-tjsp-plans-vs-sus.md</p>
<hr />
<h1>Sintese Tjsp Planos Vs Sus</h1>
<p>Documento analítico em formato markdown, pronto para consulta.</p>
<hr />
<h1>TJSP: Private Plans vs SUS Cases - How Arguments Differ</h1>
<h2 id="overview">Overview</h2>
<p>The Tribunal de Justiça de São Paulo (TJSP) handles the largest volume of health litigation in Brazil. This memo maps the distinct argumentative structures used in private health plan cases versus SUS (public health) cases.</p>
<hr />
<h2 id="1-volume-and-distribution">1. Volume and Distribution</h2>
<h3 id="tjsp-health-case-profile-2024-estimates">TJSP Health Case Profile (2024 estimates)</h3>
<table>
<thead>
<tr>
  <th>Type</th>
  <th>Annual Volume</th>
  <th>% of Total</th>
</tr>
</thead>
<tbody>
<tr>
  <td>Planos de Saúde (private)</td>
  <td>~180,000</td>
  <td>55%</td>
</tr>
<tr>
  <td>SUS (public)</td>
  <td>~120,000</td>
  <td>37%</td>
</tr>
<tr>
  <td>Mixed/Other</td>
  <td>~25,000</td>
  <td>8%</td>
</tr>
</tbody>
</table>
<h3 id="jurisdictional-organization">Jurisdictional Organization</h3>
<ul>
<li><strong>Varas da Fazenda Pública</strong>: SUS cases against State/Municipality</li>
<li><strong>Varas Cíveis</strong>: Private plan cases</li>
<li><strong>Juizados Especiais</strong>: Lower-value claims (both types)</li>
</ul>
<hr />
<h2 id="2-fundamental-legal-frameworks">2. Fundamental Legal Frameworks</h2>
<h3 id="private-plans">Private Plans</h3>
<table>
<thead>
<tr>
  <th>Source</th>
  <th>Application</th>
</tr>
</thead>
<tbody>
<tr>
  <td>CDC (Lei 8.078/90)</td>
  <td>Consumer protection, abusive clauses</td>
</tr>
<tr>
  <td>Lei 9.656/98</td>
  <td>Health plans regulation</td>
</tr>
<tr>
  <td>ANS Resolutions</td>
  <td>Coverage requirements, rol</td>
</tr>
<tr>
  <td>Contract</td>
  <td>Specific terms (subject to CDC limits)</td>
</tr>
</tbody>
</table>
<h3 id="sus-cases">SUS Cases</h3>
<table>
<thead>
<tr>
  <th>Source</th>
  <th>Application</th>
</tr>
</thead>
<tbody>
<tr>
  <td>CF/88 Art. 196</td>
  <td>Constitutional right</td>
</tr>
<tr>
  <td>Lei 8.080/90</td>
  <td>SUS organic law</td>
</tr>
<tr>
  <td>RENAME/PCDT</td>
  <td>Incorporated treatments</td>
</tr>
<tr>
  <td>STF Temas</td>
  <td>6, 793, 1.234 requirements</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="3-core-argumentative-differences">3. Core Argumentative Differences</h2>
<h3 id="3-1-the-plaintiff-s-burden">3.1 The Plaintiff's Burden</h3>
<p><strong>Private Plans:</strong></p>
<pre><code>Plaintiff must show:
1. Valid contract exists
2. Treatment was prescribed
3. Plan denied coverage
4. Denial lacks contractual/legal basis

Burden then SHIFTS to plan to justify denial (CDC)
</code></pre>
<p><strong>SUS Cases:</strong></p>
<pre><code>Plaintiff must show (post-Tema 6):
1. Medical necessity (prescription)
2. Financial incapacity (if non-incorporated drug)
3. No therapeutic substitute in SUS
4. If not incorporated: CONITEC didn't expressly reject
5. Evidence-based efficacy

Burden remains largely on plaintiff
</code></pre>
<h3 id="3-2-the-quot-medical-prescription-quot-argument">3.2 The &quot;Medical Prescription&quot; Argument</h3>
<p><strong>Private Plans:</strong></p>
<blockquote>
<p>Medical prescription creates strong presumption of medical necessity. Plan must prove treatment is experimental or excluded.</p>
</blockquote>
<p><strong>SUS Cases:</strong></p>
<blockquote>
<p>Medical prescription is necessary but NOT sufficient. Must also show drug meets incorporation criteria or Tema 6 requirements.</p>
</blockquote>
<h3 id="3-3-financial-arguments">3.3 Financial Arguments</h3>
<p><strong>Private Plans:</strong></p>
<blockquote>
<p>Irrelevant. Plan cannot deny based on cost if treatment is covered. &quot;Reserva do possível&quot; doesn't apply to private contracts.</p>
</blockquote>
<p><strong>SUS Cases:</strong></p>
<blockquote>
<p>Central issue. &quot;Reserva do possível&quot; (budgetary limits) is a valid defense. But &quot;mínimo existencial&quot; (core rights) trumps budget when life/health at immediate risk.</p>
</blockquote>
<hr />
<h2 id="4-defendant-s-typical-defenses">4. Defendant's Typical Defenses</h2>
<h3 id="private-plan-defenses">Private Plan Defenses</h3>
<table>
<thead>
<tr>
  <th>Defense</th>
  <th>Court Response</th>
</tr>
</thead>
<tbody>
<tr>
  <td>&quot;Not on ANS rol&quot;</td>
  <td>Rejected if no effective substitute (Lei 14.454/2022)</td>
</tr>
<tr>
  <td>&quot;Experimental treatment&quot;</td>
  <td>Must prove; ANVISA registration defeats this</td>
</tr>
<tr>
  <td>&quot;Contractual exclusion&quot;</td>
  <td>Often deemed abusive under CDC</td>
</tr>
<tr>
  <td>&quot;Waiting period&quot;</td>
  <td>Doesn't apply to emergencies</td>
</tr>
<tr>
  <td>&quot;Pre-existing condition&quot;</td>
  <td>Must have required prior exams (Súmula 609)</td>
</tr>
</tbody>
</table>
<h3 id="state-municipality-defenses-sus">State/Municipality Defenses (SUS)</h3>
<table>
<thead>
<tr>
  <th>Defense</th>
  <th>Court Response</th>
</tr>
</thead>
<tbody>
<tr>
  <td>&quot;Not incorporated&quot;</td>
  <td>Valid, but Tema 6 may override</td>
</tr>
<tr>
  <td>&quot;Wrong federative entity&quot;</td>
  <td>Tema 793 - solidarity, but can redirect</td>
</tr>
<tr>
  <td>&quot;Reserva do possível&quot;</td>
  <td>Valid for non-essential; rejected for life-threatening</td>
</tr>
<tr>
  <td>&quot;Administrative path not exhausted&quot;</td>
  <td>Post-SV 60, increasingly accepted</td>
</tr>
<tr>
  <td>&quot;No evidence of efficacy&quot;</td>
  <td>Valid - plaintiff must prove</td>
</tr>
<tr>
  <td>&quot;Therapeutic substitute exists&quot;</td>
  <td>Valid if substitute is truly equivalent</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="5-tutela-de-urg-ncia-patterns">5. Tutela de Urgência Patterns</h2>
<h3 id="private-plans-almost-always-granted">Private Plans (Almost Always Granted)</h3>
<p><strong>Standard reasoning:</strong></p>
<blockquote>
<p>&quot;Presente a probabilidade do direito, consubstanciada na prescrição médica e na existência de contrato válido, bem como o perigo de dano à saúde do autor, defere-se a tutela de urgência.&quot;</p>
</blockquote>
<p><strong>Denial is rare:</strong></p>
<ul>
<li>Clearly cosmetic procedure</li>
<li>Manifestly experimental (no ANVISA)</li>
<li>Evident fraud</li>
</ul>
<h3 id="sus-cases-more-scrutinized">SUS Cases (More Scrutinized)</h3>
<p><strong>Post-2024 reasoning:</strong></p>
<blockquote>
<p>&quot;Necessário verificar o cumprimento dos requisitos fixados no Tema 6/STF e a consulta ao NAT-Jus antes da concessão liminar.&quot;</p>
</blockquote>
<p><strong>Standard questions:</strong></p>
<ol>
<li>Is drug incorporated (RENAME/PCDT)?<ul>
<li>Yes → Grant easily</li>
<li>No → Apply Tema 6 requirements</li>
</ul>
</li>
<li>Is there therapeutic substitute?</li>
<li>Was administrative request made?</li>
<li>What does NAT-Jus say?</li>
</ol>
<hr />
<h2 id="6-damage-awards-comparison">6. Damage Awards Comparison</h2>
<h3 id="private-plans">Private Plans</h3>
<table>
<thead>
<tr>
  <th>Situation</th>
  <th>Typical Moral Damages</th>
</tr>
</thead>
<tbody>
<tr>
  <td>Simple denial, quick resolution</td>
  <td>R$ 5.000 - R$ 10.000</td>
</tr>
<tr>
  <td>Denial causing treatment delay</td>
  <td>R$ 10.000 - R$ 20.000</td>
</tr>
<tr>
  <td>Denial during ongoing treatment</td>
  <td>R$ 20.000 - R$ 40.000</td>
</tr>
<tr>
  <td>Denial leading to worsening/death</td>
  <td>R$ 50.000 - R$ 200.000+</td>
</tr>
</tbody>
</table>
<p><strong>Material damages:</strong> Full treatment cost + consequential losses</p>
<h3 id="sus-cases">SUS Cases</h3>
<table>
<thead>
<tr>
  <th>Situation</th>
  <th>Typical Outcome</th>
</tr>
</thead>
<tbody>
<tr>
  <td>Medication granted</td>
  <td>No moral damages (mere exercise of right)</td>
</tr>
<tr>
  <td>Proven bad faith delay</td>
  <td>R$ 5.000 - R$ 15.000 (rare)</td>
</tr>
<tr>
  <td>Treatment denial causing death</td>
  <td>Possible, but rare and contested</td>
</tr>
</tbody>
</table>
<p><strong>Key difference:</strong> Moral damages against the State are harder to obtain; system failure is harder to prove than contractual breach.</p>
<hr />
<h2 id="7-recurring-argumentative-patterns">7. Recurring Argumentative Patterns</h2>
<h3 id="private-plan-cases-plaintiff-s-winning-arguments">Private Plan Cases - Plaintiff's Winning Arguments</h3>
<ol>
<li><p><strong>&quot;Rol exemplificativo&quot;</strong></p>
<blockquote>
<p>O rol da ANS é exemplificativo, não podendo o plano negar cobertura quando não há substituto terapêutico eficaz.</p>
</blockquote>
</li>
<li><p><strong>&quot;Médico assistente decide&quot;</strong></p>
<blockquote>
<p>Cabe ao médico assistente, e não ao plano de saúde, definir o tratamento adequado.</p>
</blockquote>
</li>
<li><p><strong>&quot;Cláusula abusiva&quot;</strong></p>
<blockquote>
<p>A cláusula contratual que exclui cobertura para tratamento prescrito é abusiva à luz do CDC.</p>
</blockquote>
</li>
<li><p><strong>&quot;Expectativa legítima&quot;</strong></p>
<blockquote>
<p>O consumidor contrata plano de saúde com legítima expectativa de cobertura ampla.</p>
</blockquote>
</li>
</ol>
<h3 id="sus-cases-plaintiff-s-winning-arguments">SUS Cases - Plaintiff's Winning Arguments</h3>
<ol>
<li><p><strong>&quot;Direito fundamental&quot;</strong></p>
<blockquote>
<p>O direito à saúde é direito fundamental, de eficácia imediata, oponível ao Estado.</p>
</blockquote>
</li>
<li><p><strong>&quot;Mínimo existencial&quot;</strong></p>
<blockquote>
<p>O fornecimento do medicamento integra o mínimo existencial, não podendo ser negado por razões orçamentárias.</p>
</blockquote>
</li>
<li><p><strong>&quot;Risco de vida&quot;</strong></p>
<blockquote>
<p>Demonstrado o risco de morte ou grave dano à saúde, impõe-se a concessão.</p>
</blockquote>
</li>
<li><p><strong>&quot;Tema 6 cumprido&quot;</strong></p>
<blockquote>
<p>O autor comprovou todos os requisitos do Tema 6/STF: hipossuficiência, ausência de substituto, eficácia comprovada.</p>
</blockquote>
</li>
</ol>
<h3 id="defendant-s-winning-arguments">Defendant's Winning Arguments</h3>
<p><strong>Plans:</strong></p>
<ol>
<li>&quot;Tratamento experimental sem registro ANVISA&quot;</li>
<li>&quot;Procedimento estético sem indicação médica corroborada&quot;</li>
<li>&quot;Fraude comprovada na contratação&quot;</li>
</ol>
<p><strong>State/SUS:</strong></p>
<ol>
<li>&quot;Existe substituto terapêutico incorporado ao SUS&quot;</li>
<li>&quot;CONITEC avaliou e não recomendou incorporação&quot;</li>
<li>&quot;Ausência de prova de eficácia baseada em evidências&quot;</li>
<li>&quot;Autor não demonstrou hipossuficiência financeira&quot;</li>
</ol>
<hr />
<h2 id="8-tjsp-specialized-structures">8. TJSP Specialized Structures</h2>
<h3 id="cadip-centro-de-apoio-ao-direito-p-blico">CADIP (Centro de Apoio ao Direito Público)</h3>
<ul>
<li>Issues thematic guidance on health litigation</li>
<li>Publishes the &quot;Caderno de Judicialização da Saúde&quot;</li>
<li>Provides judges with technical support</li>
</ul>
<h3 id="nat-jus-sp">NAT-Jus SP</h3>
<ul>
<li>Technical opinions for judges</li>
<li>Connected to e-NatJus national system</li>
<li>Increasing use post-SV 60</li>
</ul>
<h3 id="c-maras-especializadas">Câmaras Especializadas</h3>
<ul>
<li>Câmaras de Direito Público: SUS cases</li>
<li>Câmaras de Direito Privado: Plan cases</li>
</ul>
<hr />
<h2 id="9-trends-and-evolution">9. Trends and Evolution</h2>
<h3 id="private-plans">Private Plans</h3>
<ul>
<li><strong>Increasing:</strong> Mental health coverage disputes</li>
<li><strong>Increasing:</strong> Home care / home infusion</li>
<li><strong>Stable:</strong> Oncology treatment denials</li>
<li><strong>Decreasing:</strong> Rol disputes (after Lei 14.454)</li>
</ul>
<h3 id="sus">SUS</h3>
<ul>
<li><strong>Increasing:</strong> Ultra-high-cost drugs (gene therapy)</li>
<li><strong>Increasing:</strong> Cannabis-based medications</li>
<li><strong>Stable:</strong> Oncology (APAC system issues)</li>
<li><strong>Decreasing:</strong> Basic incorporated drugs (administrative improvements)</li>
</ul>
<hr />
<h2 id="10-practical-checklist-for-case-analysis">10. Practical Checklist for Case Analysis</h2>
<h3 id="private-plan-case">Private Plan Case</h3>
<ul>
<li class="task-list-item"><input class="task-list-item-checkbox" type="checkbox" disabled/>Contract exists and is valid?</li>
<li class="task-list-item"><input class="task-list-item-checkbox" type="checkbox" disabled/>Treatment prescribed by licensed physician?</li>
<li class="task-list-item"><input class="task-list-item-checkbox" type="checkbox" disabled/>ANVISA registered?</li>
<li class="task-list-item"><input class="task-list-item-checkbox" type="checkbox" disabled/>On ANS rol or no effective substitute?</li>
<li class="task-list-item"><input class="task-list-item-checkbox" type="checkbox" disabled/>Exclusion clause applies? Is it abusive?</li>
<li class="task-list-item"><input class="task-list-item-checkbox" type="checkbox" disabled/>Emergency situation?</li>
<li class="task-list-item"><input class="task-list-item-checkbox" type="checkbox" disabled/>Moral damages elements present?</li>
</ul>
<h3 id="sus-case">SUS Case</h3>
<ul>
<li class="task-list-item"><input class="task-list-item-checkbox" type="checkbox" disabled/>Treatment incorporated (RENAME/PCDT)?<ul>
<li>Yes → Straightforward grant</li>
<li>No → Continue checklist</li>
</ul>
</li>
<li class="task-list-item"><input class="task-list-item-checkbox" type="checkbox" disabled/>Tema 6 requirements met?<ul>
<li>Financial incapacity proven?</li>
<li>CONITEC didn't reject?</li>
<li>No therapeutic substitute?</li>
<li>Evidence of efficacy?</li>
</ul>
</li>
<li class="task-list-item"><input class="task-list-item-checkbox" type="checkbox" disabled/>Correct defendant (Tema 793)?</li>
<li class="task-list-item"><input class="task-list-item-checkbox" type="checkbox" disabled/>NAT-Jus consulted?</li>
<li class="task-list-item"><input class="task-list-item-checkbox" type="checkbox" disabled/>Administrative request made (SV 60)?</li>
</ul>
<hr />
<h2 id="key-documents-to-cross-reference">Key Documents to Cross-Reference</h2>
<ul>
<li><code>data/stf_teses/caderno-judicializacao-saude-tjsp-3ed-2024.pdf</code> - TJSP official guidance</li>
<li><code>data/stj_teses/tjrj-plano-saude-sumulas.pdf</code> - Comparison with TJRJ</li>
<li><code>data/cnj_resolucoes/resolucao-238-2016-forum-saude.pdf</code> - Specialized courts</li>
<li><code>data/legislacao_processual/</code> - Procedural vehicles</li>
</ul>

</div>
</main>

<footer>
  Generated by <code>bash build.sh site</code>
</footer>

</body>
</html>
